RecruitingNCT06135870
Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)
Role of Senescent Cells in Uterine Fibroid Pathogenesis
Sponsor
Johns Hopkins University
Enrollment
150 participants
Start Date
Nov 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
The investigators are evaluating the role of senescent cells in uterine fibroids.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 55 Years
Inclusion Criteria4
- Subjects must be women above the age of ≥18 - ≤55 years.
- Women with suspected uterine fibroids.
- Subject must be or have been sexually active or have had a previous vaginal exam that used a speculum.
- Subject must be able to understand, read and speak English or Spanish and subsequently, be able to understand what she is consenting to in terms of procedures and use/disclosure of protected health information.
Exclusion Criteria3
- Unwilling to sign the consent form or complete questionnaire.
- Pregnancy.
- Cancer of the uterus
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06135870
Related Trials
Prescription of Letrozole for Uterine Myoma
NCT061436315 locations
An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms
NCT070786821 location
Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor Diagnosis
NCT070781361 location
Effects of Simvastatin on Uterine Leiomyoma Size
NCT034008261 location
Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology
NCT0639299713 locations